Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After

Taku Inohara1,2, Shun Kohsaka3, Hiroaki Miyata4

  • 1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Insights

Subsequent acute coronary syndromes (ACS) after percutaneous coronary intervention (PCI) increase mortality risk. However, unplanned revascularization or unstable angina alone did not significantly impact long-term survival in PCI patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Composite endpoints are common in percutaneous coronary intervention (PCI) trials.
  • The individual impact of PCI outcomes on long-term survival needs further clarification.

Purpose of the Study:

  • To assess the association between post-PCI acute coronary syndromes (ACS) and unplanned revascularization with long-term survival.
  • To differentiate the prognostic impact of individual components within composite endpoints.

Main Methods:

  • Analysis of the KiCS-PCI registry (2009-2011) including 3348 patients undergoing PCI.
  • Propensity-matched cohorts compared survival between patients with and without subsequent ACS or unplanned revascularization.
  • Cox proportional hazard models evaluated 2-year all-cause mortality, with a separate analysis for unstable angina.

Main Results:

  • A subsequent ACS event was associated with a significantly increased mortality risk (HR, 4.73; P=0.015).
  • Unplanned revascularization did not show a statistically significant increase in mortality risk (HR, 2.97; P=0.19).
  • Unstable angina events, a subset of ACS, were not significantly associated with increased mortality (HR, 1.39; P=0.54).

Conclusions:

  • Subsequent ACS events post-PCI are linked to higher mortality.
  • The prognostic significance of unplanned revascularization and unstable angina alone is less pronounced.
  • Consideration of individual component implications is crucial for interpreting composite endpoints in PCI clinical trials.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
315
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
315
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
477